Drug Use by Music Festival Attendees: A Novel Triangulation Approach Using Self-Reported Data and Test Results of Oral Fluid and Pooled Urine Samples by Gjerde, Hallvard et al.
Accepted Manuscript 
This is an Accepted Manuscript of an article published by 
Taylor & Francis Group in Substance Use & Misuse on 09 August 2019, 
available online: 
http://www.tandfonline.com/10.1080/10826084.2019.1646285 
Hallvard Gjerde, Linn Gjersing, Jose Antonio Baz-Lomba, Lubertus Bijlsma, 
Noelia Salgueiro-González, Håvard Furuhaugen, Anne Line Bretteville-Jensen, 
Félix Hernández, Sara Castiglioni, Ellen Johanna Amundsen & Ettore Zuccato 
(2019) Drug Use by Music Festival Attendees: A Novel Triangulation Approach 
Using Self-Reported Data and Test Results of Oral Fluid and Pooled Urine 
Samples, Substance Use & Misuse, 54:14, 2317-2327.
1 
 
Drug use by music festival attendees: A novel and comprehensive triangulation 
approach using self-reported data and test results of oral fluid and pooled urine samples 
Hallvard Gjerde
a
, Linn Gjersing
b
, Jose Antonio Baz-Lomba
c
, Lubertus Bijlsma
d
, Noelia 
Salgueiro-González
e
, Håvard Furuhaugen
a
, Anne Line Bretteville-Jensen
b
, Félix Hernández
d
, 
Sara Castiglioni
e
, Ellen Johanna Amundsen
b
, Ettore Zuccato
e 
 
a
Section of Drug Abuse Research, Department of Forensic Sciences, Oslo University 
Hospital, Oslo, Norway  
b
Department of Alcohol, Tobacco and Drugs, Norwegian Institute of Public Health, Oslo, 
Norway 
c
Norwegian Institute for Water Research, Oslo, Norway 
d
Research Institute for Pesticides and Water, University Jaume I, Castellón, Spain 
e
Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy 
 
ORCiD: 
Hallvard Gjerde: 0000-0003-1465-3128 
Linn Gjersing:  0000-0003-0829-2020 
Jose Antonio Baz-Lomba: 0000-0002-4923-3337 
Lubertus Bijlsma: 0000-0001-7005-8775 
Noelia Salgueiro-González: 0000-0002-4079-658X  
Anne Line Bretteville-Jensen: 0000-0001-5356-2777 
Félix Hernández: 0000-0003-1268-3083 
Sara Castiglioni: 0000-0002-7313-8495 
Ellen Johanna Amundsen: 0000-0001-9754-1628  
  
2 
 
Corresponding author: 
Hallvard Gjerde. E-mail address: hallvard.gjerde@ous-hf.no  
Oslo University Hospital 
Department of Forensic Sciences  
Section for Drug Abuse Research 
P. O. Box 4950 Nydalen  
NO-0424 Oslo, Norway  
 
Word count (excluding abstract, references, tables, and figures): 3569 
  
3 
 
ABSTRACT 
Background: Self-reported data are most commonly used when investigating illicit substance 
use. However, self-reports have well-known limitations such as recall bias and socially 
desirable responding.  
Objectives: We sought to examine illicit substance use among music festival attendees using 
a novel combination of self-reported data and drug testing of biological samples (oral fluid 
and pooled urine), to determine what can be gained in terms of illicit drug findings when 
including biological sample test results. 
Methods: We included 651 attendees at three music festivals in Norway from June to August 
2016. Self-reported drug use was recorded using questionnaires, and samples of oral fluid 
(mixed saliva) were analyzed to detect use of illicit drugs. In addition, we analyzed samples of 
pooled urine from portable toilets at each festival.  
Results: Using all three methods, we identified cannabis, MDMA, and cocaine as the most 
commonly used drugs. Overall, 6.6% of respondents reported use of illicit substances during 
the previous 48 hours whereas 12.6% tested positive for illicit drugs in oral fluid. In oral fluid 
testing, we identified four new psychoactive substances (NPS) that had not been reported on 
the questionnaire, and three additional NPS were detected in pooled urine testing. 
Amphetamine use was detected in testing of pooled-urine samples from festivals where none 
of the included participants reported such use or tested positive for this substance in oral fluid.  
Conclusions/Importance: Drug testing of biological samples proved to be an important 
supplement to self-reports as a larger number of illicit substances could be detected. 
 
 
Keywords: recreational drug use; illicit drugs; music festivals; self-reported drug use; oral 
fluid; pooled urine; drug testing 
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Introduction 
Illicit substance use is most commonly studied using self-reported data collected via 
questionnaires and/or interviews (Johnson & VanGeest, 2017; Sloboda, 2002). In addition to 
detailed information on drug use and consumption history, individual data on a range of 
potentially important variables can be collected for every respondent. However, self-reports 
have well-known limitations, such as under- or overreporting of actual drug use. Incorrect 
reporting may result from factors such as recall bias and socially desirable responding 
(Johnson & Richter, 2004; Johnson & Fendrich, 2005). Selection bias may also be a problem, 
either because participants are non-randomly recruited or because some subgroups may have a 
lower probability of participation (Harrison & Hughes, 1997; Johnson, 2014).  
One particular problem for studies on the use of illegal drugs is that users may not know 
exactly what they have consumed (EMCDDA, 2016b; Tanner-Smith, 2006; Togni, Lanaro, 
Resende, & Costa, 2015; Vogels et al., 2009). The problem may apply in particular to 
inexperienced users, but even experienced users may not always know the true content of the 
substances used. This problem may have increased in recent years as a large number of so-
called New Psychoactive Substances (NPS) have appeared on the drug market. These mainly 
include synthetic stimulants, depressants, hallucinogens, and cannabinoids (EMCDDA, 2017; 
Nelson, Bryant, & Aks, 2014), but some plant-based drugs may also be classified as NPS 
(Schifano, Orsolini, Duccio Papanti, & Corkery, 2015). In cases where sales information or 
labels exist, these may be inaccurate or misleading (Scherbaum, Schifano, & Bonnet, 2017; 
UNODC, 2016) or the chemical name may be difficult to remember. Hence, even when 
reporting to the best of their knowledge, users may still do so incorrectly.  
An alternative to self-reports is drug testing of biological samples such as urine, oral fluid, 
sweat, hair, or blood (Fendrich, Johnson, & Becker, 2017; Fendrich, Johnson, Wislar, 
Hubbell, & Spiehler, 2004; Gjerde, Øiestad, & Christophersen, 2011), which may be used to 
detect recent use of a wide range of substances. Analysis of NPS, however, presents a 
challenge compared with that of classical illicit drugs due to the large number of new 
substances and rapid changes in availability, as well as a complex pattern of metabolites in 
urine samples.  
Wastewater-based epidemiology (WBE) has been recognized as a complementary tool for 
objectively monitoring the use of illicit drugs at population level (Bade et al., 2017; Brewer, 
Banta-Green, Ort, Robel, & Field, 2016; Burgard, Banta-Green, & Field, 2014; Thomas et al., 
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2012; Zuccato, Chiabrando, Castiglioni, Bagnati, & Fanelli, 2008). The methodology has 
recently also been explored for NPS (Bade et al., 2017; Gonzalez-Marino, Gracia-Lor, Rousis, 
et al., 2016); in the latter case, the above challenges also exist for WBE in relation to the low 
incidence of NPS use and therefore low concentrations in wastewater.  
As an alternative to wastewater, analysis of pooled urine samples can be used to evaluate the 
consumption of both classical and new psychoactive drugs (Archer, Hudson, Wood, & 
Dargan, 2013; Mardal et al., 2017). Drug concentrations are obviously higher in pooled urine 
than in wastewater due to the much lower dilution factor, thereby increasing the possibility of 
detecting rarely used drugs, which is an important advantage. Few samples are needed, and a 
large number of different substances can be analyzed using the same sample, which represents 
a large number of individuals. As with wastewater testing, informed consent from individuals 
is not needed, and the sampling process is neither intrusive nor invasive. A disadvantage is 
that information about the participants is difficult to collect, including the number of people 
contributing to the pooled urine sample. Therefore, pooled urine testing does not contribute to 
estimating prevalence of illicit drug use. Nevertheless, pooled urine testing is a useful tool for 
determining the types of drugs consumed. 
Advanced analytical methodologies are required to examine drugs in wastewater, pooled 
urine, oral fluid, or other biological samples, particularly for NPS (Hernandez et al., 2018). 
The most common approach is the monitoring of only specified substances. This allows 
quantification of very low drug concentrations in the samples, using techniques like liquid 
chromatography (LC) coupled to tandem mass spectrometry (MS/MS). Although this 
approach is highly useful and robust, it cannot be used to detect drugs that are not among the 
targeted compounds. Alternatively, the use of LC coupled to high-resolution mass 
spectrometry (HRMS), linked to large mass spectral libraries, enables qualitative screening 
(i.e., detection and identification) of a large number of drugs, when quantification is not a 
primary objective. This is of particular relevance when many drugs are investigated, and/or 
when reference standards are not all available in the laboratory, which is a common situation 
when dealing with NPS.  
Studies of nightlife settings and events such as music festivals have reported high rates of 
illicit substance use (Bijlsma, Serrano, Ferrer, Tormos, & Hernandez, 2014; Gripenberg-
Abdon et al., 2012; Hesse & Tutenges, 2012; Hoegberg et al., 2018; Jenkinson, Bowring, 
Dietze, Hellard, & Lim, 2014; Johnson, Voas, Miller, & Holder, 2009; Lim, Hellard, 
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Hocking, & Aitken, 2008; Mohr, Friscia, Yeakel, & Logan, 2018; Riley, James, Gregory, 
Dingle, & Cadger, 2001). Particularly high rates have been found at electronic dance music 
(EDM) events (Hesse & Tutenges, 2012; Johnson et al., 2009; Mohr et al., 2018; Riley et al., 
2001). In addition to the use of classical drugs such as cannabis, amphetamines, cocaine, and 
MDMA (ecstasy), the use of NPS has been detected, although at much lower levels than for 
classical drugs (Hoegberg et al., 2018; Riley et al., 2001).  
To the best of our knowledge, no previous studies have combined self-reported data and test 
results for drugs in oral fluid and pooled urine samples in settings such as music festivals. In 
this study, we aimed to determine what could be gained in terms of illicit drug use findings 
among music festival attendees when including biological sample test results in the 
assessment. 
 
Materials and methods 
Setting 
Norway has a population of 5.2 million and the largest city has approximately 600,000 
inhabitants. We selected three music festivals in Norway during the summer of 2016 for this 
study: a pop/rock music festival and an EDM festival, which both took place in a large city 
(>200,000 inhabitants), and a pop/rock music festival in a small town in a rural area. All three 
festivals had several thousand (8,500–20,000) visitors on each day of the festival.  
Recruitment of participants 
At each festival site, a geographical recruitment area was defined. These were located in high-
traffic areas, such as close to the entrances or exits or near toilet facilities. Data collection 
began between 7:00 and 9:00 p.m. and continued for about 3 to 4 hours, until about 200 
participants had been recruited. All festivals had a large number of patrons passing through 
the selected area(s); it was therefore not possible to invite all patrons to participate or to use 
systematic random sampling. Consequently, this was a convenience sample. Participants were 
informed of the study and consented to taking part in the study. Data were collected using a 
questionnaire, and participants provided an oral fluid sample for drug testing; blood alcohol 
concentrations were determined using a breathalyzer. Participants received a voucher for food 
or soft drinks in lieu of reimbursement. Further details on participant recruitment and data 
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collection have been previously published (Gjersing, Bretteville-Jensen, Furuhaugen, & 
Gjerde, 2019).  
Participant recruitment and collection of data and oral fluid samples were approved by the 
Regional Committee for Medical and Health Research Ethics (approval no. 2016/337). 
Self-report data 
A questionnaire for self-completion was used to record data on age, sex, education (less than 
12 years; 12–13 years; bachelor’s degree or higher), occupation (full-time job; part-time job; 
student; unemployed; sick leave), and self-reported use of cannabis, amphetamines, 
MDMA/ecstasy, cocaine, NPS, and MOP (which was a fictitious “dummy substance”, to 
study the extent of overreporting) during the previous 48 hours and the previous 12 months 
(yes/no for each drug class).  
Oral fluid samples 
Oral fluid samples were collected using the Intercept® Oral Fluid Collection Device (OraSure 
Technologies Inc., Bethlehem, PA, USA). Samples of oral fluid were analyzed to detect 
classical recreational drugs and a selection of NPS using ultra high-performance LC-MS/MS. 
The sample preparation and analytical methods have been described previously (Gjerde et al., 
2016). Samples were analyzed by testing for either the active drug or inactive metabolites; this 
was done for classical illicit drugs (amphetamines, MDMA, cocaine, cannabis, LSD, and 
heroin) as well as for 22 NPS, which were selected based on the opinion of experts and the 
types of NPS that participants reported using (see Supplementary Table S1). Sample extracts 
were reanalyzed to confirm tentative NPS findings using LC-HRMS with a quadrupole time-
of-flight (q-TOF) mass spectrometer. Analytical data were matched with an in-house mass 
spectral library of approximately 1700 compounds. 
Pooled urine samples 
After each study day, the portable toilets on the festival grounds were emptied into a sewage 
disposal truck. Pooled urine samples were collected from the truck between 6:00 and 8:00 
a.m. The samples were analyzed for the presence of a larger number of NPS than for the oral 
fluid samples due to differences in analytical methodologies; see Supplementary Table S1 for 
details. Qualitative analyses were performed for more than 190 NPS with HRMS using both 
quadrupole-time-of-flight and Orbitrap® (Thermo Fischer Scientific, Waltham, MA, USA) 
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mass spectrometers, as described elsewhere (Bade et al., 2015; Gonzalez-Marino, Gracia-Lor, 
Bagnati, et al., 2016). We used mass spectral libraries or specific publications for 
identification of substances. 
Quantitative analyses were performed with LC-MS/MS (Bade et al., 2017; Bijlsma, Beltran, 
Boix, Sancho, & Hernandez, 2014; Gonzalez-Marino, Gracia-Lor, Rousis, et al., 2016; 
Zuccato et al., 2016) for the same classical illicit drugs as listed above in oral fluid testing, 
except for LSD. Some selected NPS (mostly synthetic cathinones) were also quantified. The 
referenced quantitative methods were adapted (i.e., sample preparation and pre-concentration 
steps) and validated for the analysis of pooled urine, as these original methods were developed 
for the determination of illicit drugs and NPS in wastewater.  
For cannabis, we only tested its main metabolite, 11-nor-9-carboxy-Δ9-tetrahydrocannabinol 
(THC-COOH) in pooled urine because the active substance tetrahydrocannabinol (THC) is 
mainly metabolized to THC-COOH and excreted via urine. This metabolite is generally used 
as a stable biomarker for cannabis in wastewater analysis (Bijlsma, Serrano, et al., 2014; 
Thomas et al., 2012).  
Statistical analysis 
We used Pearson’s chi-squared test for categorical data to compare age distributions, 
education, and drug use among attendees at the three festivals.  
 
Results 
Questionnaire responses 
Approximately half of the 651 study participants (n=320) were females. The proportion of 
participants younger than age 24 years was significantly higher at the EDM festival than the 
two pop/rock festivals (χ2=201.3, p<0.001), and a larger proportion had not completed 
bachelor’s degree or higher education (χ2=136.2, p<0.001). Most attendees at the pop/rock 
festivals had full-time jobs, and four out of five held a bachelor’s degree or higher. 
Characteristics of the three music festivals and the study cohorts are presented in Table 1. 
 
[Insert Tables 1 and 2 near here] 
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In total, 6.6% of respondents reported use of illicit drugs during the previous 48 hours. 
Cannabis was the most commonly reported, followed by MDMA and cocaine, in both the 
previous 48 hours and the previous 12 months (Tables 1 and 2). A larger proportion of the 
participants at the EDM festival reported use of MDMA during the previous 48 hours than 
attendees at the other festivals (χ2=8.8, p=0.003).  
Only 10 participants reported lifetime use of NPS, five during the previous 12 months and 
only one within the previous 48 hours. Respondents were only asked to specify the types of 
NPS used during their lifetime and not those used in the previous 48 hours; three participants 
reported having tried synthetic cannabinoids or “spice”, two reported having used 2C-B (a 
psychedelic drug), one had used Salvia divinorum, and four did not specify which substance 
they had used.  
Oral fluid test results 
Illicit drugs were found in 12.6% of oral fluid samples. The most commonly detected drugs 
were THC, cocaine, and MDMA, the proportions and frequencies of which varied among the 
three festivals (Table 2).  
Similar to the questionnaire responses, a larger proportion of participants at the EDM festival 
tested positive for MDMA (χ2=11.1, p=0.001) and cocaine (χ2=9.5, p=0.002) than attendees at 
the two pop/rock festivals. At the same time, a smaller proportion of participants tested 
positive for THC at the pop/rock festival in the small town than attendees at the two festivals 
in large cities (χ2=10.3, p=0.001). In analysis of oral fluid samples, we detected the use of four 
NPS: alpha-PVP, dimethyltryptamine, ketamine, and 2C-B.  
Pooled urine test results 
In line with self-reports and results of oral fluid sample testing, analysis of pooled urine also 
revealed the highest proportion of MDMA use at the EDM festival. The highest 
concentrations of cocaine and its metabolite were found in the pooled urine sample from the 
pop/rock festival in the large city, with relatively high levels of MDMA detected as well. The 
sample from the small-town pop/rock festival showed the highest concentration of THC-
COOH. Overall, three NPS were detected: methcathinone, 4-chloro-alpha-PPP, and 2-
phenethylamine.  
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In some cases, a drug or its metabolite was found in pooled urine but it was not found in oral 
fluid samples nor its use reported on the questionnaires (amphetamines at the two pop/rock 
festivals and cocaine at the small town pop/rock festival; Table 2). Conversely, at the EDM 
festival, the use of cannabis was confirmed in self-reports and oral fluid testing but not in the 
pooled urine test results. A comparison of the three festivals based on self-reports and oral 
fluid testing was therefore slightly different than a comparison of the festivals using the 
pooled urine test results.  
Finally, only 29 of the 82 persons who tested positive for illicit drugs in oral fluid, including 
NPS, reported having used the detected substance or NPS during the previous 48 hours. 
Among those who tested positive for cannabis, 51.3% reported such use during the previous 
48 hours, whereas among those testing positive for cocaine or MDMA, only 25.5% reported 
such use (χ2=6.1, p=0.014).  
 
Discussion 
To the best of our knowledge, this is the first study of illicit drug use at music festivals that 
combines self-reports with drug testing of both oral fluid and pooled urine samples. Although 
all methods identified the three same most commonly used drugs, the biological sample test 
results identified a larger number of illicit substances than the self-reports. Drug testing of 
biological samples therefore appears to be an important supplement to self-reports when 
investigating illicit substance use. 
The biological sample test results and questionnaire responses indicated that the type of 
substances used differed among festivals. MDMA was more common among EDM festival 
attendees whereas cocaine was more common among participants at the pop/rock festival in 
the large city. At the small-town pop/rock festival, cannabis was the most commonly reported 
substance; few participants had used other drugs, as confirmed by analytical testing of oral 
fluid or pooled urine, and no one reported use of any other substance during the previous 48 
hours.  
Each of the three methods used—questionnaires, oral fluid sample testing, and pooled urine 
sample testing—have strengths and weaknesses. The use of a questionnaire enables the 
collection of sociodemographic data and information of self-reported drug use over a longer 
time period than can be detected with analysis of oral fluid or urine. We also used the 
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questionnaire to collect data that are not presented in this article, such as the frequency and 
amount of drug use, other drug use habits, and some risk assessments.  
Oral fluid drug testing is a more objective method to determine recent drug use than self-
reporting. This methodology can be used to detect a large number of substances; we included 
29 individual substances in our study; however, the number of oral fluid samples was 
relatively low. Each festival had thousands of attendees per day, so the selected study cohorts 
of about 200 people per festival constituted a small fraction of the total attendees at each 
event. Consequently, it was not possible to accurately estimate the prevalence rate of 
substance use in each festival, and it is possible that we did not detect all NPS used. However, 
the latter was the main strength of the pooled urine samples; using pooled urine testing, we 
were able to identify substances not detected using the questionnaire or in oral fluid analysis.  
It is difficult to estimate the prevalence rate of drug use based on pooled urine testing. It is 
also difficult to quantitatively compare the drug use levels at the different festivals because 
the number of participants contributing to the public toilet samples was unknown. In addition, 
the total drug dose per user might have been different at each festival.  
Overall, all three methods had individual weaknesses, but when used in combination, these 
were able to strengthen the findings.  
Discrepancies between self-reported data and results of oral fluid and urine testing 
The use of cocaine and MDMA during the previous 48 hours was clearly underreported. 
Underreporting was investigated in greater detail in a study including participants from six 
music festivals, including the three festivals in the present study (Gjerde, Gjersing, 
Furuhaugen, & Bretteville-Jensen, 2019). Underreporting has also been observed in previous 
studies (Gripenberg-Abdon et al., 2012; Harrison & Hughes, 1997; Johnson et al., 2009; 
Rendon, Livingston, Suzuki, Hill, & Walters, 2017); the magnitude may depend on age, sex, 
race, as well as type of drug (Harris, Griffin, McCaffrey, & Morral, 2008; Johnson, 2014; 
Rendon et al., 2017; Rosay, Najaka, & Herz, 2007). For example, there seems to be less 
hesitancy to report the use of cannabis than the use of amphetamine and cocaine in some 
settings (Gripenberg-Abdon et al., 2012; Johnson et al., 2009), possibly because the use of the 
latter drugs are more stigmatized. This seemed to be the case in our study as well. 
Drug findings in oral fluid and pooled urine samples are not directly comparable. Drug 
detection in oral fluid samples mostly reflects drug use during the previous 10–50 hours, 
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depending on the type of drug, whereas drug findings in urine samples may reflect drug use 
during the previous several days (Verstraete, 2004). Analysis of pooled urine samples 
revealed some drugs that were neither reported as having been used nor found in oral fluid 
samples; this is because the drugs found in pooled urine reflected drug intake by all users of 
the portable toilets during the entire festival day and not only the selection of participants who 
provided oral fluid samples and completed the questionnaire. However, the discrepancy for 
cannabis at the EDM festival suggests that pooled urine testing is less sensitive than oral fluid 
testing in detection of cannabis use; this has also been previously reported to be a challenge in 
wastewater drug testing (Causanilles et al., 2017).  
Furthermore, drugs might have been intentionally or unintentionally dumped into the public 
toilets, causing elevated drug concentrations that do not reflect actual drug use. The latter 
might have occurred for cocaine, as the observed ratio between cocaine and benzoylecgonine 
concentrations (3.4 and 1.8 for the two pop/rock festivals, respectively) was much higher than 
the commonly observed concentration ratios in wastewater (0.42±0.28), which reflects the 
excretion rate of human metabolism (EMCDDA, 2016a). 
Combining the three methods 
The findings when using the three methods were somewhat different; no single method gave a 
very complete picture of drug use in the studied cohorts. Combining the three types of data, 
each with distinctive pros and cons, gave the most comprehensive picture of drug use.  
The three methods had advantages and limitations, with some overlapping information 
regarding qualitative data. Self-reports and oral fluid samples provided specific information 
on illicit drugs and NPS prevalence whereas pooled urine analysis showed generic use in the 
studied cohorts. The wide-scope screening methodologies used and the large number of 
festival attendees contributing to the urine samples allowed for the potential detection of a 
very large number of drugs (190 NPS plus all traditional drugs); therefore, we were able to 
detect drugs whose use had not been reported.  
 
Conclusions 
The combination of three methods used in this study provided the most complete picture of 
illicit drug use. Although all methods identified the same three most commonly used drugs, 
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the biological sample test results identified a larger number of illicit substances than the self-
reports. The drug testing of biological samples therefore proved to be an important 
supplement to self-reporting. Future studies examining the type of substances used in a 
specific setting have much to gain by the addition of these methods. Our findings may be 
helpful in policy making and drug-related harm reduction. 
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Table 1. Characteristics of music festivals and participants. 
 Pop/rock 
festival (large 
city) 
EDM festival 
(large city) 
Pop/rock 
festival 
(small town) 
No. of attendees (approximate, per d) 20,000 18,000 8,500 
No. of study participants 226 205 220 
Male sex (%) 46.5 54.1 47.3 
Age, y (%)    
   16–23 15.5 74.1 18.6 
   24–30 47.3 21.5 41.8 
   31–40 25.7 3.9 25.9 
   41+ 10.6 0.0 13.6 
   Not recorded 0.9 0.5 0.0 
Education (%)     
   Bachelor’s degree or higher 79.6 33.2 80.5 
Employment status, previous 30 d (%)    
   Full-time 72.6 42.4 69.1 
   Part-time or student 23.0 52.7 24.1 
   Unemployed 4.4 4.9 6.4 
   Not recorded 0.0 0.0 0.5 
Self-report drug use, previous 12 mo (%)    
   Amphetamines 2.7 5.9 0.5 
   Cocaine 6.6 7.3 2.3 
   MDMA 6.6 10.0 0.9 
   Cannabis 23.5 23.9 18.2 
   NPS 0.0 1.5 0.9 
   MOP 0.0 1.5 0.0 
Abbreviations: EDM, electronic dance music; NPS, new psychoactive substances.
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Table 2. Quantitative and qualitative results of analysis of pooled urine and oral fluid, and self-reported use of illicit drugs and NPS in the previous 48 
hours. 
 Pop/rock festival (large city)  EDM festival (large city)  Pop/rock festival (small town)  
Drug testing Self-reported 
use previous 
48 h (%) 
Drug testing Self-reported 
use previous 
48 h (%) 
Drug testing Self-reported 
use previous 
48 h (%) 
Pooled 
urine 
(µg/L) 
Oral 
fluid 
(%) 
Pooled 
urine 
(µg/L) 
Oral 
fluid 
(%) 
Pooled 
urine 
(µg/L) 
Oral fluid 
(%) 
Amphetamine 4.9 0.0 0.0 5.4 0.0 1.0 8.3 0.0 0.0 
Methamphetamine 3.8 0.0 - 1.6 0.0 - 1.6 0.0 - 
Cocaine/benzoylecgonine
a
 46.2/13.4 4.0/1.8 1.3 7.9/11.0 6.8/2.0 2.0 1.7/0.9 0.0 0.0 
MDMA (ecstasy) 28.6 4.0 1.3 38.3 7.3 3.9 3.0 0.0 0.0 
Cannabis  
  (THC/THC-COOH
b
) 
n.a./1.3 8.8/n.a
. 
5.8 n.a./ 0.0 7.3/n.a
. 
7.8 n.a./3.3 1.8/n.a. 1.8 
NPS See 
below 
1.3 0.0 See 
below 
0.9 0.5 See 
below 
0.9 0.0 
Methcathinone 0.3 n.a. - 0.0 n.a. - 0.0 n.a. - 
4-chloro-alpha-PPP Positive
c
 n.a. - n.a. n.a. - n.a. n.a. - 
2-phenethylamine Positive n.a. - Positive n.a. - Positive n.a. - 
Alpha-PVP 0.0 0.4 - n.a. 0.0 - n.a. 0.0 - 
Dimethyltryptamine n.a. 0.0 - n.a. 0.0 - n.a. 0.9 - 
Ketamine 0.1 0.0 - 0.0 0.9 - 0.0 0.0 - 
2C-B n.a. 0.9 - n.a. 0.0 - n.a. 0.0 - 
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a
Inactive metabolite of cocaine. 
b
Inactive metabolite of THC.  
c
Tested positive, not quantified.  
n.a.: not analyzed.   
-: not queried. 
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Supplementary material  
Table S1. Cut-off concentrations for illicit substances analyzed in oral fluid or pooled urine samples using 
quantitative methods. 
Illicit substance 
Neat oral fluid
 
(µg/L)
a
 
Pooled urine 
(µg/L) 
   
    Cannabis   
        Tetrahydrocannabinol 0.37 n.a. 
        Carboxy-tetrahydrocannabinol n.a. 0.060 
    Central stimulants   
        Amphetamine 15 0.10 
        Benzoylecgonine 4.3 0.060 
        Cocaine 1.1 0.060 
        MDMA (ecstasy) 2.3 0.060 
        Methamphetamine 8.9 0.060 
    Illicit opiate   
        Heroin n.a. 0.10 
        6-monoacetylmorphine 4.7 0.060 
    Hallucinogen   
        LSD 0.019 n.a. 
    NPS
c
   
        25B-NBOMe n.a. 0.10 
        25C-NBOMe 0.048 0.10 
        25I-NBOMe 0.062 0.10 
        2C-B 0.23 n.a. 
        2C-I 0.28 n.a. 
        3,4-dimethylcathinone n.a. 0.060 
        3,4-methylenedioxy-pyrovalerone 0.50 0.060 
        4-fluoromethcathinone n.a 0.060 
        4-methylamphetamine 0.54 n.a. 
        4-methylcathinone n.a. 0.060 
        5F-APINACA 0.093 n.a. 
        5F-PB-22 0.091 n.a. 
        Alpha-PVP 0.13 0.10 
        AM-2201 0.087 n.a. 
        Buphedrone n.a. 0.060 
        Butylone n.a. 0.060 
        Diclazepam 0.19 n.a. 
        Dimethyltryptamine 0.11 n.a. 
        Ethcathinone n.a. 0.060 
        Ethylone n.a. 0.060 
        Ethylphenidate 0.15 n.a. 
        Etizolam 0.22 n.a. 
        Flubromazepam 0.20 n.a. 
        Flubromazolam 0.22 n.a. 
        Ketamine 0.34 0.060 
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Table S1 continued. 
  
Substance 
Neat oral fluid 
(µg/L)
a
 
Pooled urine 
(µg/L) 
        Mephedrone 0.11 0.060 
        Methcathinone n.a. 0.060 
        Methedrone n.a. 0.060 
        Methiopropamine 0.087 n.a. 
        Methylone n.a. 0.060 
        Naphyrone n.a. 0.060 
        Penthedrone n.a. 0.060 
        Pentylone n.a. 0.060 
        Salvinorin A 3.1 n.a. 
        THJ-2201 0.087 n.a. 
        UR-144 0.075 n.a. 
a
Assuming that 0.4 mL oral fluid was collected and mixed with 0.8 mL preservative buffer.   
n.a.: not analyzed. 
 
 
